Hints and tips:
...In September last year, President Joe Biden also issued an order telling Cfius to pay close attention to deals involving critical technologies, including artificial intelligence, quantum computing and biotechnology...
...the private equity industry, HIG had in recent years expanded its investment focus, using success in corporate buyouts to push into strategies spanning real estate credit, infrastructure, software and biotechnology-oriented...
...Nasdaq’s lower listing fees and costs mean many smaller companies choose to float there, including capital-hungry biotechnology groups which frequently tap the market for funds — generating fees for their...
...Their departures follow the announcement earlier this year that Ronen Israel, a senior principal and 22-year veteran of AQR, would be stepping down to help start a biotechnology company....
...The ARKK fund has backed risky companies that it sees as radically reshaping the future in technology, robotics, biotechnology and space exploration....
...A cancer-focused biotechnology company has sued eight of the US’s largest market-making traders including Citadel Securities, Susquehanna and Virtu, alleging that they deliberately drove down its share price...
...The start-up that owns the biotechnology behind the Oxford/AstraZeneca vaccine has confidentially filed for an initial public offering in the US, Indian social media group ShareChat has raised more than...
...Ronen Israel, one of its top executives, is now leaving to help start a biotechnology company after 22 years at the firm, while Lars Nielsen, his fellow co-head of portfolio management, is shifting to a...
...“There is a high degree of overlap between investors and speculators in Tesla shares, bitcoin and other cryptocurrencies, Ark Invest funds and related stocks such as the biotechnology stocks,” said Garnry...
...He cited machine learning, biotechnology and materials science as interesting sectors. 3....
...They will be replaced by cloud software provider Salesforce, biotechnology company Amgen, and industrial goods conglomerate Honeywell International....
...The writer is co-founder and principal of Rice, Hadley, Gates & Manuel LLC, a consulting firm Roman roads, Chinese gunpowder, British steamships, repeating firearms: great power competition has always been...
...Beer battle: Kirin vs FP Target: Kirin Activist: Franchise Partners Late last year, UK-based FP launched a campaign to persuade the Japanese brewer to focus on making beer instead of branching out into biotechnology...
...Companies such as BridgeBio Pharma and Adaptive Biotechnologies have raised hundreds of millions of dollars on Nasdaq this year, in part attracted by the exchange’s biotech index....
...Barclays has hired David Parrot for its biotechnology investment banking group. Parrot, who joins from SunTrust Robinson Humphrey, will be based in California....
...He highlighted biotechnology and manufacturing among other areas he would be discussing with South Korea but nuclear power is expected to top the agenda because of the urgency of attracting investors to...
...In January, Google participated in the latest funding round for Chinese esports livestreaming platform Chushou, and AI biotechnology start-up XtalPi’s $15m series B funding round....
...The Los Angeles Times has been sold to the biotechnology billionaire Patrick Soon-Shiong by Tronc for $500m....
...Google participated in the latest funding round for Chinese esports livestreaming platform Chushou at the beginning of January and artificial intelligence biotechnology start-up XtalPi last week said Google...
...The Los Angeles Times has been sold to the biotechnology billionaire Patrick Soon-Shiong for $500m by US publisher Tronc following months of turmoil at its flagship newspaper....
...The Nasdaq biotechnology index clocked its biggest one-day drop since June 24 on Wednesday as pressure mounted on Mylan over an increase of the price of a life-saving drug....
...Biotechnology stocks, meanwhile, have struggled: The Nasdaq biotech index has shed a quarter of its value over the period....
...Ron Tilles has been named as the biotechnology company’s interim chief, according to an emailed statement on Friday....
...KaloBios, a US micro-cap biotechnology company, said it let Mr Shkreli go on December 17....
...activities, accounting for 31 per cent of the money it put to work this year — also potentially puts it into competition with Calico, a division of Alphabet run by Art Levinson, a former chief executive of biotechnology...
International Edition